U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Medical Devices
  3. Medical Devices News and Events
  4. Virtual Public Workshop – Extended Reality in Orthopedic Surgical Devices: Insights into User Experience and Adverse Event Reporting for Patient Safety - November 2, 2023 - 11/02/2023
  1. Medical Devices News and Events

Workshop | Virtual

Event Title
Virtual Public Workshop – Extended Reality in Orthopedic Surgical Devices: Insights into User Experience and Adverse Event Reporting for Patient Safety - November 2, 2023
November 2, 2023

Date:
November 2, 2023
Time:
9:00 AM - 1:00 PM ET

SUMMARY

The Food and Drug Administration (FDA) is announcing a virtual public workshop entitled “Extended Reality in Orthopedic Surgical Devices: Insights into User Experience and Adverse Event Reporting for Patient Safety.” The workshop will provide a public forum for engaging with orthopedic community, device manufacturers, regulatory affairs professionals, clinicians, patients and the general public.  It will focus on stakeholders’ experiences associated with advanced surgical systems in orthopedic surgery that incorporate extended reality (XR) technologies, including stereotaxic navigation and robotic-assisted surgical systems.  The workshop is intended to enhance the FDA’s understanding of user experience and initiates an exchange of ideas that may facilitate the development of innovative methods for assessing and monitoring device performance.  The presentations will review current education, training, and adverse event reporting to promote patient safety.   

BACKGROUND

In recent years, XR technology which includes Augmented Reality (AR), Virtual Reality (VR), and Mixed Reality (MR) has led to the development of new paradigms for diagnosis, preoperative planning, and surgical treatment for orthopedic extremities and spinal disorders. Compared to traditional stereotaxic systems these advancements are intended to improve ergonomics, precision, accuracy, patient outcomes and decrease surgical time. 

Since 2019, when the first orthopedic surgical system with integrated XR technology received FDA clearance, there has been only limited information available on user experience.  While there have been adverse events reported to FDA, there has been limited information available on training, education, and adverse event reporting by users of these systems. Reported adverse events include surgical delays, conversions to non-navigated (manual) techniques, and direct patient harms due to a myriad of factors such as inaccurate bone resection or implant misplacement. Transparency with regards to best practices employed by end users to assure the precision and accuracy of XR technologies is vital for ensuring safe and effective use of these systems. 

For more information on adverse event reporting, please refer to the FDA website on Medical Device Reporting (MDR): How to Report Medical Device Problems at https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems

The Center for Devices and Radiological Health (CDRH) has initiated several efforts to facilitate the understanding of XR technologies.  See Digital Health Center of Excellence, “Augmented Reality and Virtual Reality in Medical Devices” website at https://www.fda.gov/medical-devices/digital-health-center-excellence/augmented-reality-and-virtual-reality-medical-devices. 

The information gathered through stakeholder engagement at this public workshop may also provide insight into potential best practices related to using XR technologies in orthopedic surgery and foster a collaborative approach to patient safety. The workshop is not intended to address non-orthopedic surgical devices. 

DATE and TIME

This virtual meeting will be held on November 2, 2023, from 9:00 a.m. to 1:00 p.m. ET by webcast only. 

WEBCAST

November 2nd webcast: https://fda.yorkcast.com/webcast/Play/762512358f8f4fd8856ec15ece9542341d

AGENDA

Time Subject Name of Speaker
9:00 a.m. – 9:15 a.m. Welcome and Opening Remarks CAPT Raquel Peat, PhD, MPH, Director, 
OHT6: Office of Orthopedic Devices, Office 
of Product Evaluation and Quality (OPEQ), CDRH, FDA
Master of Ceremony - Christopher Harner, MD, Deputy Director, OHT6: Office of Orthopedic Devices, OPEQ, CDRH
9:15 a.m. - 9:25 a.m. Overview of Extended Reality Technology in Orthopedics CDR Michel Janda, MS, Lead Reviewer, OHT6, OPEQ, CDRH, FDA
9:25 a.m. - 9:35 a.m. FDA Perspectives on Training and Education Bart Sachs, MD, MBA, FACHE, Medical Officer, OHT6: OPEQ, CDRH, FDA
9:35 a.m. - 9:45 a.m. Industry Perspective on Training and Education  Kimberly Walker
Sr. Director Robotics Education, Stryker
9:45 a.m. - 9:55 a.m. Perspectives on Clinician Training and Education - Spine Procedures Ronald A. Lehman Jr., MD
Professor of Orthopedics-Columbia Univ
9:55 a.m. - 10:05 a.m. Perspectives on Clinician Training and Education - Knee and Hip Replacement Brett Levine, MD, MS, FAOA Professor of Orthopedic Surgery
Rush University Medical Center
10:05 a.m. - 10:15 a.m. Perspectives on Clinician- Shoulder Procedures Danny P. Goel, MD, MBA, MSc, FRCSC
CEO & Clinical Professor of Orthopedics-PrecisionOS
10:15 a.m. - 10:25 a.m. Perspectives on Clinician - Training and Education on Trauma Procedures Greg M. Osgood, MD, FACS, FAOA, FAAOS
Associate Professor, Johns Hopkins Department of Orthopaedic Surgery
10:25 a.m. - 10:45 a.m. FDA’s Infographics for Augmented Reality and Virtual Reality Devices; Critical Questions to Consider for Patients and Healthcare Professionals

Leeda Rashid, MD, MPH, ABFM
Physician, Digital Health Center of Excellence, Office of Strategic Partnerships and Technology Innovation, FDA

Aubrey Shick MS, Sr. Digital Health Advisor, Digital Health Center of Excellence, Office of Strategic Partnerships and Technology Innovation, FDA
10:45 a.m. - 11:00 a.m. Clinical Discussion on Education and Training  Moderators: David Scott, MD, Medical Officer & Christopher Harner, MD, Clinical Deputy Director, OHT6: Office of Orthopedic Devices, OPEQ, CDRH, FDA
11:00 a.m. - 11:10 a.m. BREAK
11:10 a.m. - 11:20 a.m. Overview of Extended Reality Technologies Mark Zhang, DO, MMsc
President, American Medical Extended Reality Association
11:20 a.m. - 11:30 a.m. Office of Science and Engineering Laboratories (OSEL) and Training Discussion Ryan Beams, PhD, Physicist, Division of Imaging Diagnostics and Software Reliability, OSEL, CDRH, FDA
11:30 a.m. - 11:40 a.m. Mixed Reality Operating Room Beth Ann Ripley, MD, PhD
Deputy Chief, Healthcare Innovation & Learning, VHA
11:40 a.m. - 11:50 a.m. Standard Testing Facility Zane Arp, PhD, 
Director Division of Biomedical Physics, OSEL, CDRH, FDA
11:50 a.m. - 12:10 p.m. Technical Discussion Moderators: David Scott, MD, Medical Officer, OHT6, OPEQ, and Ryan Beams, PhD, Physicist, OSEL, CDRH, FDA
12:10 p.m. - 12:20 p.m.     FDA Expectations for Mandatory and Voluntary Reporters Shumaya Ali, MPH, Assistant Director, OHT6, OPEQ, CDRH, FDA
12:20 p.m. - 12:30 p.m. Adverse Events in Action: Proactive Reporting and Best Practices Madris Kinard, MBA
Founder and CEO Device Events
12:30 p.m. - 12:40 p.m. MAUDE and MedWatch Matter to My Practice: A Case-Series Jonathan Dubin, MD Associate Professor of Orthopedic Surgery University of Missouri – Kansas City
12:40 p.m. - 12:50 p.m. Clinical Discussion on Adverse Events Moderators: David Scott, MD, Medical Officer and Christopher Harner, MD, Clinical Deputy Director, OHT6: Office of Orthopedic Devices, OPEQ, CDRH, FDA
12:55 p.m. - 1:00 p.m. Closing Remarks

Laurence D. Coyne, PhD, Division Director, OHT6: Office of Orthopedic Devices, OPEQ, CDRH, FDA

REGISTRATION

If you wish to attend this Workshop, you must register by 4:00 p.m. on November 1, 2023.  
There is no fee to register for the Workshop. Registration will be on a first-come, first-served basis. When registering, you must provide the following information: 

(1) Webcast  
(2) Name 
(3) Title 
(4) Affiliation, Company or Organization
(5) E-mail address 
(6) Telephone number
(7) Stakeholder Category (Academia, Clinician, Consultant, Government, Industry, Regulatory and Other) 

Registrants will receive confirmation when requests for participation have been accepted.  

If you require special accommodations due to a disability, or need additional information regarding registration, please contact Susan Monahan, Office of Communication and Education, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Bldg. 32, Silver Spring, MD 20993, 301-796-5661, Susan.Monahan@fda.hhs.gov by October 27, 2023

SUBMIT COMMENTS

Please submit your comments regarding the workshop to https://www.regulations.gov/, Docket No. FDA-2023-N-4298 by December 3, 2023.    

Please refer to the Instructions for submitting comments to the docket to ensure that your feedback is received.  

The resulting discussions from the workshop and comments received in the docket will be taken into consideration.

Please be advised that as soon as a transcript is available, it will be posted in the Dockets and accessible at https://www.regulations.gov/.  

CONTACT

For questions regarding workshop content please contact:

CDR Randoshia Miller
Office of Health Technology 6
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
 
Email: OHT6-Feedback@fda.hhs.gov

Event Materials

Title File Type/Size
Instructions for Submitting Comments - Ortho Surgical Procedures Workshop pdf (143.15 KB)
 
Back to Top